Home > Formulary : Adult > Chapters > 6. Endocrine System >
BNSSG Adult Joint Formulary
6.5 Dopamine responsive conditions
Last edited: 29-01-2024
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
Dopamine-receptor agonists
Alternative:
Bromocriptine (TLS Amber 3 month) (SCP click here)
Specific indication:
Quinagolide (Awaiting SCP)
- The treatment of hyperprolactinaemia & prolactinomas where other treatments have failed, are contraindicated or the patient has had adverse effects
- Quinagolide offers a non-ergot derived treatment option
Contact Us
Got a question or comment about the Joint Formulary?
Please use the email address below to contact us and we will endeavour to respond within 2 working days.